期刊文献+

外阴阴道念珠菌病的治疗及预防复发的措施 被引量:3

原文传递
导出
摘要 [目的]探讨预防外阴阴道念珠菌病复发的措施。[方法]对2007年1月至2009年1月门诊治疗的外阴阴道念珠菌病患者89例结果进行分析,探讨预防复发的措施。[结果]对照组与治疗组均于停药后的1、2和3个月,每月1次月经后复查。对照组复发率36.4%(16/44),治疗组复发率4.4%(2/45),对照组复发率高于治疗组。[结论]初次彻底的治疗,阻断性传播途径和养成良好的卫生习惯有利于预防念珠菌性阴道炎的复发。
作者 王俐萍
出处 《海峡预防医学杂志》 CAS 2010年第1期89-90,共2页 Strait Journal of Preventive Medicine
  • 相关文献

参考文献4

二级参考文献30

  • 1董德刚,常德安,李芳,孙文平,康白.乳杆菌制剂对非特异性阴道炎的治疗及其机制的研究[J].中国微生态学杂志,1994,6(2):14-18. 被引量:17
  • 2冯佩英,陆春,朱国兴,张玉清.复发性阴道念珠菌病念珠菌的菌种及药敏分析[J].临床皮肤科杂志,2005,34(4):215-217. 被引量:19
  • 3邓庆珊,杨慧霞.妊娠期外阴阴道念珠菌病[J].中国全科医学,2005,8(18):1477-1479. 被引量:13
  • 4杨景云主编.微生态学.第1版.北京:中国医药科技出版社.1997:108~240.
  • 5叶应妩,王毓三主编.全国临床检验操作规程.中华人民共和国卫生部医政司,1997:151.
  • 6Fidel PL Jr, Lynch ME, Sobel JD. Candida-specific cell-mediated immunity is demonstrable in mice with experimental vaginal candidiasis.Infect Immun, 1993,61 (5): 1990 - 1995.
  • 7Fidel PL Jr, Lynch ME, Sobel JD. Effects of preinduced Candida-specific systemic cell-mediated immunity on experimental vaginal candidiasis. Infect Immun, 1994,62 (3): 1032 - 1038.
  • 8Fidel PL Jr, Lynch ME, Sobel JD. Circulating CD4 and CD8 T cells have little impact on host defense against experimental vaginal candidiasis. Infect Immun, 1995,63 (7) :2403 - 2408.
  • 9Cantoma M, Mook D, Balish E. Resistance of congenitally immunodeficient gnotobiotic mice to vaginal candidiasis. Infect Immun, 1990,58(11) :3813 -3815.
  • 10Fidel PL Jr, Lynch ME, Conaway DH, et al. Mice immunized by primary vaginal Candida albicans infection develop acquired vaginal mucosal immunity. Infect Immun, 1995, 63(2) :547 -553.

共引文献19

同被引文献27

  • 1Beikert FC,Le MT,Koeninger A,et al.Recurrent vulvovaginal candidosis: focus on the vulva[J].Mycoses,2011,54(6):e807-810.
  • 2Del Pup L.Treatment of atrophic and irritative vulvovaginal symptoms with an anhydrous lipogel and its complementary effect with vaginal es- trogenic therapy: new evidences[J].Minerva Ginecol,2010,62(4):287-291.
  • 3Hoffstetter S,Barr S,LeFevre C,et al.Telephone triage: diagnosis of can- didiasis based upon self-reported?vulvovaginalsymptoms [J].J Low Genit Tract Dis,2012,16(3):251-255.
  • 4Giraldo PC,Polpeta NC,Juliato CR,et al.Evaluation of sexual function in Brazilian women with recurrent vulvovaginal candidiasis and localized provoked vulvodynia[J].J Sex Med,2012,9(3):805-81 I.
  • 5Liu MB,Xu SR, He Y,et al.Diverse vaginal microbiomes in reproductive- age women with vulvovaginal candidiasis [J].PLoS 0ne,2013,8 (11): e79812.
  • 6Vicariotto F, Del Piano M,Mogna L,et al.Effectiveness of the association of 2 probiotic strains formulated in a slow release vaginalproduct,in women affected by vulvovaginalcandidiasis: a pilot study[J].J Clin Gastroenterol, 2012,46(Suppl):S73-80.
  • 7Gupta NV,Natasha S,Getyala A,et al.Bioadhesive vaginal tablets contain- ing spray dried microspheres loaded with clotrimazole for treatment of vaginal Candidiasis[J].Acta Pharm,2013,63(3):359-372.
  • 8Chopra V,Marotta F,Kumari A,et al.Prophylactic strategies in recurrent vulvovaginal candidiasis: a 2-year study testing a phytonutrient vs itra- conazole[J].J Biol Regul Homeost Agents,2013,27(3):875-882.
  • 9Sekhavat L,Tabatabaii A,Tezerjani FZ.Oral fluconazole 150 mg single dose versus intra-vaginal clotrimazole treatment of acute vulvovaginal candidiasis[J].J Infect Public Health,2011,4(4):195-199.
  • 10Sobel JD. Vulvovaginal candidosis[J].The Lancet,2007,(9577):1961-1971.

引证文献3

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部